Debbie's Dream Foundation Partners with KIBOUNOKAI to Empower the Japanese Community in Stomach Cancer Awareness and Education [Yahoo! Finance]
DAIICHI SANKYO S/ADR (DSNKY)
NASDAQ:AMEX Investor Relations:
daiichisankyo.com/media_investors/investor_relations/index.html
Company Research
Source: Yahoo! Finance
May 24, 2024 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) is thrilled to announce a new international partnership with KIBOUNOKAI, a renowned non-profit organization based in Tokyo, Japan . The collaboration, formalized on May 1, 2024 , marks a significant step in DDF's mission to raise awareness globally, advance research, and provide education and support for stomach cancer patients, families, and caregivers. The partnership will leverage the strengths of both organizations to disseminate critical information about stomach cancer, promote early detection, and support patients through comprehensive educational initiatives. Hiromi Todoroki , Chairwoman of KIBOUNOKAI and Director of the Japan Federation of Cancer Patient Groups, will be pivotal in driving these efforts. Hiromi co-founded KIBOUNOKAI following her personal experience with her husband, Tetsuya Todoroki , who was diagnosed with stage IV gastric cancer. Despite regular cancer screenings, Tetsuy
Show less
Read more
Impact Snapshot
Event Time:
DSNKY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DSNKY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DSNKY alerts
High impacting DAIICHI SANKYO S/ADR news events
Weekly update
A roundup of the hottest topics
DSNKY
News
- Datopotamab Deruxtecan Final Overall Survival Results Reported in Patients with Metastatic HR Positive, HER2 Low or Negative Breast Cancer in TROPION-Breast01 Phase 3 Trial [Yahoo! Finance]Yahoo! Finance
- Datopotamab Deruxtecan Final Overall Survival Results Reported in Patients with Metastatic HR Positive, HER2 Low or Negative Breast Cancer in TROPION-Breast01 Phase 3 TrialBusiness Wire
- NHS England to offer Daiichi Sankyo's quizartinib for AML [Yahoo! Finance]Yahoo! Finance
- Daiichi Sankyo: Showing No Signs Of Slowing Down ADC Dominance [Seeking Alpha]Seeking Alpha
- Daiichi Sankyo and MSD's ADC improves progression-free survival in NSCLC trial [Yahoo! Finance]Yahoo! Finance